Literature DB >> 2819919

Baclofen disrupts passive avoidance retention in rats.

H S Swartzwelder, H A Tilson, R L McLamb, W A Wilson.   

Abstract

Baclofen (Lioresal, Ciba-Geigy) is an analog of the inhibitory neurotransmitter GABA and is used clinically to control spasticity. Recent studies have demonstrated that this compound produces a marked inhibition of synaptically evoked responses in area CA3 of the hippocampal slice, suggesting that this drug could influence behavior mediated by the limbic system. In the present study, male rats of the Fischer-344 strain were trained on a one-trial passive avoidance task and tested for retention 1 week later. After the training trial, separate groups of rats received either 5 or 10 mg/kg/4 ml IP of baclofen or the distilled H2O vehicle immediately, 10 min, or 60 min after training. One week later, the rats that received baclofen immediately after training reentered the test chamber with a significantly higher frequency than controls, although no differences in vacillatory responses were observed between groups. Similar effects were observed following posttrial administration of chlordiazepoxide. In a separate experiment rats were tested for locomotor activity after receiving the same doses of baclofen. Although baclofen decreased activity during a 30-min period after dosing, rats exposed to baclofen showed no significant change in activity relative to controls 1 week later. These data are consistent with the interpretation that baclofen may interfere with memory consolidation or retention.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2819919     DOI: 10.1007/BF00210851

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

1.  Action of baclofen on mammalian synaptic transmission.

Authors:  S Fox; K Krnjević; M E Morris; E Puil; R Werman
Journal:  Neuroscience       Date:  1978       Impact factor: 3.590

Review 2.  Hormonal influences on memory.

Authors:  J L McGaugh
Journal:  Annu Rev Psychol       Date:  1983       Impact factor: 24.137

3.  Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis.

Authors:  E Knutsson; U Lindblom; A Mårtensson
Journal:  J Neurol Sci       Date:  1974-11       Impact factor: 3.181

4.  Baclofen suppresses hippocampal epileptiform activity at low concentrations without suppressing synaptic transmission.

Authors:  H S Swartzwelder; A C Bragdon; C P Sutch; B Ault; W A Wilson
Journal:  J Pharmacol Exp Ther       Date:  1986-06       Impact factor: 4.030

5.  Coexistence of GABAA and GABAB receptors on A delta and C primary afferents.

Authors:  M Désarmenien; P Feltz; G Occhipinti; F Santangelo; R Schlichter
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

6.  Direct hyperpolarizing action of baclofen on hippocampal pyramidal cells.

Authors:  N R Newberry; R A Nicoll
Journal:  Nature       Date:  1984 Mar 29-Apr 4       Impact factor: 49.962

7.  Anticonvulsant-like actions of baclofen in the rat hippocampal slice.

Authors:  B Ault; J V Nadler
Journal:  Br J Pharmacol       Date:  1983-04       Impact factor: 8.739

8.  Trimethyltin impairs retention of a passive avoidance task.

Authors:  T J Walsh; M Gallagher; E Bostock; R S Dyer
Journal:  Neurobehav Toxicol Teratol       Date:  1982 Mar-Apr

9.  Effects of benzodiazepines and pentobarbitone on the gaba-ergic recurrent inhibition of hippocampal neurons.

Authors:  T Tsuchiya; H Fukushima
Journal:  Eur J Pharmacol       Date:  1978-04-15       Impact factor: 4.432

10.  Pre- and postsynaptic effects of baclofen in the rat hippocampal slice.

Authors:  T J Blaxter; P L Carlen
Journal:  Brain Res       Date:  1985-08-19       Impact factor: 3.252

View more
  6 in total

1.  The interaction between hippocampal GABA-B and cannabinoid receptors upon spatial change and object novelty discrimination memory function.

Authors:  Mohammad Nasehi; Niyousha Alaghmandan-Motlagh; Mohaddeseh Ebrahimi-Ghiri; Mohammad Nami; Mohammad-Reza Zarrindast
Journal:  Psychopharmacology (Berl)       Date:  2017-08-05       Impact factor: 4.530

2.  The effects of baclofen and two GABAB-receptor antagonists on long-term potentiation.

Authors:  H R Olpe; G Karlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

3.  Baclofen administration alters fear extinction and GABAergic protein levels.

Authors:  Chelcie F Heaney; Monica M Bolton; Andrew S Murtishaw; Jonathan J Sabbagh; Christy M Magcalas; Jefferson W Kinney
Journal:  Neurobiol Learn Mem       Date:  2012-09-23       Impact factor: 2.877

4.  Administration of GABA(B) receptor positive allosteric modulators inhibit the expression of previously established methamphetamine-induced conditioned place preference.

Authors:  Robin M Voigt; Amy A Herrold; Jennifer L Riddle; T Celeste Napier
Journal:  Behav Brain Res       Date:  2010-09-08       Impact factor: 3.332

5.  Potential interactions between GABAb and cholinergic systems: baclofen augments scopolamine-induced performance deficits in the eight-arm radial maze.

Authors:  E S Sidel; H A Tilson; R L McLamb; W A Wilson; H S Swartzwelder
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Effect of fendiline on the maintenance and expression of methamphetamine-induced conditioned place preference in Sprague-Dawley rats.

Authors:  Robin M Voigt; Jennifer L Riddle; T Celeste Napier
Journal:  Psychopharmacology (Berl)       Date:  2013-11-22       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.